GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Shares Buyback Ratio %

Australian Clinical Labs (ASX:ACL) Shares Buyback Ratio % : 0.00 (As of Jun. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Australian Clinical Labs's current shares buyback ratio was 0.00%.

Australian Clinical Labs Shares Buyback Ratio % Historical Data

The historical data trend for Australian Clinical Labs's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Shares Buyback Ratio % Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Shares Buyback Ratio %
- 0.25 - -

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Buyback Ratio % Get a 7-Day Free Trial 0.50 -0.50 0.66 -0.66 0.66

Australian Clinical Labs Shares Buyback Ratio % Calculation

Australian Clinical Labs's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2022 ) - Shares Outstanding (EOP) (A: Jun. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2022 )
=(201.834 - 201.834) / 201.834
=0.00%

Australian Clinical Labs's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(201.834 - 200.503) / 201.834
=0.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australian Clinical Labs Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Shares Buyback Ratio %
Comparable Companies
ASX:MVF ASX:IDX ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:HLS ASX:LDX ASX:CTE ASX:GTG TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Website
https://www.clinicallabs.com.au
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines